The Medical Affairs and Regulatory Science team at Orchard Therapeutics PLC plays a crucial role in supporting the development and commercialization of gene and cell therapies. They are responsible for ensuring that scientific and regulatory standards are met throughout the product lifecycle, facilitating communication between clinical development and healthcare providers, and providing strategic guidance on regulatory requirements. This team collaborates to generate and disseminate scientific evidence, navigate regulatory challenges, and ultimately ensure that innovative therapies reach patients in need.
Anne-Isabelle Prevot
Director, Regulatory Science
Batika Rana
Principal Scientist
Dr. Mirko Essing
Head Medical Affairs Eumea
Jason Bablak
Vice President, Regulatory Sci...
Katie Snell
Associate Director, Global Med...
Sairah Mohammad
QC Manager
Samantha Williams
Director, US Regulatory Scienc...
Sean Moro
Director, Medical Communicatio...
Stefano Bruni
Senior Director Medical Affair...
Valerie Pimpaneau
Vice President Regulatory CMC
View all